SCHEMBL9325985

SCHEMBL9325985

COP(C)(=O)C1CC(c2ccccc2)=NO1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.40
▸ KMT2A Q03164 3/20 0.40
▸ MAPT P10636 1/20 0.40
▸ MIF P14174 3/20 0.39
▸ LMNA P02545 4/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ ESR1 P03372 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ ATM Q13315 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9327263 0.87 MAOB (0.42) ALDH1A1KMT2AMIFLMNASMN1; SMN2
SCHEMBL9327334 0.86 MIF (0.52) MIFLMNANPC1POLBRAB9A
SCHEMBL9751216 0.84 CA1 (0.48) CA1CA2ALDH1A1KMT2ALMNA
SCHEMBL9327057 0.82 CA1 (0.49) CA1CA2ALDH1A1KMT2AMAPT
SCHEMBL9326044 0.78 CA1 (0.51) CA1CA2ALDH1A1KMT2AMIF
SCHEMBL9751233 0.78 CA1 (0.43) CA1CA2ALDH1A1KMT2AMAPT
SCHEMBL9327386 0.76 SORT1 (0.39) KMT2ALMNASMN1; SMN2MEN1TSHR
SCHEMBL9751158 0.70 MIF (0.56) KMT2AMIFLMNANPC1POLB
SCHEMBL9751234 0.69 MME (0.44) CA1CA2ALDH1A1KMT2AMAPT
SCHEMBL892413 0.69 MIF (0.76) CA1CA2KMT2AMIFLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0313997-B1 Medicine, therein contained phosphor containing 2-isoxazolidines and isoxazoles, as well as process for preparing those heterocyclic compounds HOECHST AG (DE) 1994-03-09 — — EP disclosed
US-5006515-A Immunology disorders, antitumor agent HOECHST AKTIENGESELLSCHAFT (DE) 1991-04-09 — — US disclosed
EP-0313997-A2 Medicine, therein contained phosphor containing 2-isoxazolidines and isoxazoles, as well as process for preparing those heterocyclic compounds HOECHST AKTIENGESELLSCHAFT (DE) 1989-05-03 — — EP disclosed
Send feedback